232 related articles for article (PubMed ID: 25028398)
1. Fucosyltransferase 2 (FUT2) non-secretor status and blood group B are associated with elevated serum lipase activity in asymptomatic subjects, and an increased risk for chronic pancreatitis: a genetic association study.
Weiss FU; Schurmann C; Guenther A; Ernst F; Teumer A; Mayerle J; Simon P; Völzke H; Radke D; Greinacher A; Kuehn JP; Zenker M; Völker U; Homuth G; Lerch MM
Gut; 2015 Apr; 64(4):646-56. PubMed ID: 25028398
[TBL] [Abstract][Full Text] [Related]
2. ABO blood type B and fucosyltransferase 2 non-secretor status as genetic risk factors for chronic pancreatitis.
Weiss FU; Schurmann C; Teumer A; Mayerle J; Simon P; Völzke H; Greinacher A; Kuehn JP; Zenker M; Völker U; Homuth G; Lerch MM
Gut; 2016 Feb; 65(2):353-4. PubMed ID: 26061595
[No Abstract] [Full Text] [Related]
3. Association of FUT2 and ABO with Crohn's disease in Koreans.
Ye BD; Kim BM; Jung S; Lee HS; Hong M; Kim K; Moon JW; Baek J; Oh EH; Hwang SW; Park SH; Yang SK; Song K
J Gastroenterol Hepatol; 2020 Jan; 35(1):104-109. PubMed ID: 31260595
[TBL] [Abstract][Full Text] [Related]
4. ABO histo-blood group might modulate predisposition to Crohn's disease and affect disease behavior.
Forni D; Cleynen I; Ferrante M; Cassinotti A; Cagliani R; Ardizzone S; Vermeire S; Fichera M; Lombardini M; Maconi G; de Franchis R; Asselta R; Biasin M; Clerici M; Sironi M
J Crohns Colitis; 2014 Jun; 8(6):489-94. PubMed ID: 24268527
[TBL] [Abstract][Full Text] [Related]
5. ABO, Secretor and Lewis histo-blood group systems influence the digestive form of Chagas disease.
Bernardo CR; Camargo AVS; Ronchi LS; de Oliveira AP; de Campos Júnior E; Borim AA; Brandão de Mattos CC; Bestetti RB; de Mattos LC
Infect Genet Evol; 2016 Nov; 45():170-175. PubMed ID: 27566333
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants of lipase activity in chronic pancreatitis.
Kirsten H; Scholz M; Kovacs P; Grallert H; Peters A; Strauch K; Frank J; Rietschel M; Nöthen MM; Witt H; Rosendahl J
Gut; 2016 Jan; 65(1):184-5. PubMed ID: 25814649
[No Abstract] [Full Text] [Related]
7. Genetic susceptibility factors for alcohol-induced chronic pancreatitis.
Aghdassi AA; Weiss FU; Mayerle J; Lerch MM; Simon P
Pancreatology; 2015 Jul; 15(4 Suppl):S23-31. PubMed ID: 26149858
[TBL] [Abstract][Full Text] [Related]
8. Gastric intrinsic factor deficiency with combined GIF heterozygous mutations and FUT2 secretor variant.
Chery C; Hehn A; Mrabet N; Oussalah A; Jeannesson E; Besseau C; Alberto JM; Gross I; Josse T; Gérard P; Guéant-Rodriguez RM; Freund JN; Devignes J; Bourgaud F; Peyrin-Biroulet L; Feillet F; Guéant JL
Biochimie; 2013 May; 95(5):995-1001. PubMed ID: 23402911
[TBL] [Abstract][Full Text] [Related]
9. Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival.
El Jellas K; Hoem D; Hagen KG; Kalvenes MB; Aziz S; Steine SJ; Immervoll H; Johansson S; Molven A
Cancer Med; 2017 Jul; 6(7):1531-1540. PubMed ID: 28556564
[TBL] [Abstract][Full Text] [Related]
10. Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease.
McGovern DP; Jones MR; Taylor KD; Marciante K; Yan X; Dubinsky M; Ippoliti A; Vasiliauskas E; Berel D; Derkowski C; Dutridge D; Fleshner P; Shih DQ; Melmed G; Mengesha E; King L; Pressman S; Haritunians T; Guo X; Targan SR; Rotter JI;
Hum Mol Genet; 2010 Sep; 19(17):3468-76. PubMed ID: 20570966
[TBL] [Abstract][Full Text] [Related]
11. Variation at ABO histo-blood group and FUT loci and diffuse and intestinal gastric cancer risk in a European population.
Duell EJ; Bonet C; Muñoz X; Lujan-Barroso L; Weiderpass E; Boutron-Ruault MC; Racine A; Severi G; Canzian F; Rizzato C; Boeing H; Overvad K; Tjønneland A; Argüelles M; Sánchez-Cantalejo E; Chamosa S; Huerta JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Trichopoulos D; Yiannakouris N; Palli D; Agnoli C; Tumino R; Naccarati A; Panico S; Bueno-de-Mesquita HB; Siersema PD; Peeters PH; Ohlsson B; Lindkvist B; Johansson I; Ye W; Johansson M; Fenger C; Riboli E; Sala N; González CA
Int J Cancer; 2015 Feb; 136(4):880-93. PubMed ID: 24947433
[TBL] [Abstract][Full Text] [Related]
12. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.
Wolpin BM; Kraft P; Xu M; Steplowski E; Olsson ML; Arslan AA; Bueno-de-Mesquita HB; Gross M; Helzlsouer K; Jacobs EJ; LaCroix A; Petersen G; Stolzenberg-Solomon RZ; Zheng W; Albanes D; Allen NE; Amundadottir L; Austin MA; Boutron-Ruault MC; Buring JE; Canzian F; Chanock SJ; Gaziano JM; Giovannucci EL; Hallmans G; Hankinson SE; Hoover RN; Hunter DJ; Hutchinson A; Jacobs KB; Kooperberg C; Mendelsohn JB; Michaud DS; Overvad K; Patel AV; Sanchéz MJ; Sansbury L; Shu XO; Slimani N; Tobias GS; Trichopoulos D; Vineis P; Visvanathan K; Virtamo J; Wactawski-Wende J; Watters J; Yu K; Zeleniuch-Jacquotte A; Hartge P; Fuchs CS
Cancer Epidemiol Biomarkers Prev; 2010 Dec; 19(12):3140-9. PubMed ID: 20971884
[TBL] [Abstract][Full Text] [Related]
13. ABH secretor genetic polymorphism: evidence of intrauterine selection.
Gloria-Bottini F; Magrini A; Cozzoli E; Neri A; Pietroiusti A; Amante A; Bottini E
Eur J Obstet Gynecol Reprod Biol; 2011 Jan; 154(1):20-3. PubMed ID: 21056528
[TBL] [Abstract][Full Text] [Related]
14. Relationship between ABO Blood Group Alleles and Pancreatic Cancer Is Modulated by Secretor (FUT2) Genotype, but Not Lewis Antigen (FUT3) Genotype.
Kim J; Yuan C; Amundadottir LT; Wolpin BM; ; Klein AP; ; Risch HA; Kraft P
Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1242-1248. PubMed ID: 37342060
[TBL] [Abstract][Full Text] [Related]
15. Survey and characterization of nonfunctional alleles of FUT2 in a database.
Soejima M; Koda Y
Sci Rep; 2021 Feb; 11(1):3186. PubMed ID: 33542434
[TBL] [Abstract][Full Text] [Related]
16. Fucosyltransferase Gene Polymorphisms and Lewisb-Negative Status Are Frequent in Swedish Newborns, With Implications for Infectious Disease Susceptibility and Personalized Medicine.
King JR; Varadé J; Hammarström L
J Pediatric Infect Dis Soc; 2019 Dec; 8(6):507-518. PubMed ID: 30544260
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and determinants of increased serum lipase levels in a general population.
Völzke H; Lüdemann J; Mayerle J; Kraft M; John U; Lerch MM
Pancreas; 2008 Nov; 37(4):411-7. PubMed ID: 18953254
[TBL] [Abstract][Full Text] [Related]
18. Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci.
Folseraas T; Melum E; Rausch P; Juran BD; Ellinghaus E; Shiryaev A; Laerdahl JK; Ellinghaus D; Schramm C; Weismüller TJ; Gotthardt DN; Hov JR; Clausen OP; Weersma RK; Janse M; Boberg KM; Björnsson E; Marschall HU; Cleynen I; Rosenstiel P; Holm K; Teufel A; Rust C; Gieger C; Wichmann HE; Bergquist A; Ryu E; Ponsioen CY; Runz H; Sterneck M; Vermeire S; Beuers U; Wijmenga C; Schrumpf E; Manns MP; Lazaridis KN; Schreiber S; Baines JF; Franke A; Karlsen TH
J Hepatol; 2012 Aug; 57(2):366-75. PubMed ID: 22521342
[TBL] [Abstract][Full Text] [Related]
19. Activity of the human blood group ABO, Se, H, Le, and X gene-encoded glycosyltransferases in normal and malignant bladder urothelium.
Orntoft TF; Wolf H; Watkins WM
Cancer Res; 1988 Aug; 48(15):4427-33. PubMed ID: 3134126
[TBL] [Abstract][Full Text] [Related]
20. Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity.
Taylor-Cousar JL; Zariwala MA; Burch LH; Pace RG; Drumm ML; Calloway H; Fan H; Weston BW; Wright FA; Knowles MR;
PLoS One; 2009; 4(1):e4270. PubMed ID: 19169360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
